SEK 382.8
(2.03%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 13.22 Million SEK | 7.06% |
2022 | 12.35 Million SEK | -23.54% |
2021 | 16.15 Million SEK | 187.3% |
2020 | 5.62 Million SEK | -1.42% |
2019 | 5.7 Million SEK | 0.0% |
2018 | - SEK | 0.0% |
2017 | - SEK | -100.0% |
2016 | 84.59 Million SEK | 0.0% |
2015 | - SEK | -100.0% |
2014 | 62.59 Million SEK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | - SEK | 0.0% |
2024 Q2 | 9.02 Million SEK | 0.0% |
2024 Q1 | 10.26 Million SEK | 0.0% |
2023 Q1 | 10.53 Million SEK | -14.72% |
2023 FY | 13.22 Million SEK | 7.06% |
2023 Q4 | 13.22 Million SEK | 55.42% |
2023 Q3 | 8.5 Million SEK | -8.43% |
2023 Q2 | 9.29 Million SEK | -11.79% |
2022 Q2 | 14.72 Million SEK | -4.46% |
2022 Q1 | 15.4 Million SEK | -4.61% |
2022 FY | 12.35 Million SEK | -23.54% |
2022 Q4 | 12.35 Million SEK | -7.02% |
2022 Q3 | 13.28 Million SEK | -9.77% |
2021 Q3 | 5.38 Million SEK | 37.45% |
2021 FY | 16.15 Million SEK | 187.3% |
2021 Q1 | 5.7 Million SEK | 1.46% |
2021 Q2 | 3.92 Million SEK | -31.28% |
2021 Q4 | 16.15 Million SEK | 199.78% |
2020 Q2 | 5.59 Million SEK | 30.27% |
2020 Q3 | 5.61 Million SEK | 0.2% |
2020 FY | 5.62 Million SEK | -1.42% |
2020 Q1 | 4.29 Million SEK | -24.64% |
2020 Q4 | 5.62 Million SEK | 0.21% |
2019 FY | 5.7 Million SEK | 0.0% |
2019 Q1 | 7.96 Million SEK | 0.0% |
2019 Q2 | 6.69 Million SEK | -15.92% |
2019 Q4 | 5.7 Million SEK | -0.4% |
2019 Q3 | 5.72 Million SEK | -14.45% |
2018 Q2 | - SEK | 0.0% |
2018 FY | - SEK | 0.0% |
2018 Q4 | - SEK | 0.0% |
2018 Q3 | - SEK | 0.0% |
2018 Q1 | - SEK | 0.0% |
2017 Q3 | 61.46 Million SEK | -11.51% |
2017 Q4 | - SEK | -100.0% |
2017 FY | - SEK | -100.0% |
2017 Q1 | 77.76 Million SEK | -8.08% |
2017 Q2 | 69.45 Million SEK | -10.68% |
2016 Q1 | - SEK | 0.0% |
2016 Q4 | 84.59 Million SEK | 0.0% |
2016 FY | 84.59 Million SEK | 0.0% |
2015 FY | - SEK | -100.0% |
2014 FY | 62.59 Million SEK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
AddLife AB (publ) | 2.53 Billion SEK | 99.479% |
Biotage AB (publ) | 150 Million SEK | 91.185% |
Doxa AB (publ) | 3.6 Million SEK | -267.278% |
Elekta AB (publ) | 4.8 Billion SEK | 99.725% |
iZafe Group AB (publ) | 279 Thousand SEK | -4639.068% |
Ortivus AB (publ) | 3.57 Million SEK | -269.95% |
Ortivus AB (publ) | 3.57 Million SEK | -269.95% |
Q-linea AB (publ) | 12.9 Million SEK | -2.456% |
S2Medical AB (publ) | - SEK | -Infinity% |
Synsam AB (publ) | 2.02 Billion SEK | 99.348% |